UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAS
901
DELISTED
AGL Resources Inc
GAS
| $7.76M | 0.01% |
156,311
-14,309
| -8% | -$743K |
|
902
Delek US
DK
$3.59B
| $7.73M | 0.01% |
194,569
-64,600
| -25% | -$2.14M |
|
903
ING
ING
$102B
| $7.66M | 0.01% |
523,934
-33,693
| -6% | -$461K |
|
904
iShares Core S&P Mid-Cap ETF
IJH
$127B
| $7.64M | 0.01% |
251,515
-7,545
| -3% | -$223K |
|
905
Pacira BioSciences
PCRX
$1B
| $7.64M | 0.01% |
85,999
-500
| -0.6% | -$50.7K |
|
906
Zions Bancorporation
ZION
$10.3B
| $7.52M | 0.01% |
278,491
-21,094
| -7% | -$552K |
|
907
ORIX
IX
$43.4B
| $7.49M | 0.01% |
532,530
+6,745
| +1% | +$88.2K |
|
908
Workiva
WK
$3.54B
| $7.44M | 0.01% |
516,400
-9,500
| -2% | -$132K |
|
909
Tenet Healthcare
THC
$21.1B
| $7.42M | 0.01% |
149,888
-15,487
| -9% | -$724K |
|
|
UN
910
DELISTED
Unilever NV New York Registry Shares
UN
| $7.39M | 0.01% |
+177,083
| New | +$7.43M |
|
|
UFS
911
DELISTED
DOMTAR CORPORATION (New)
UFS
| $7.37M | 0.01% |
159,450
-44,800
| -22% | -$1.89M |
|
|
NSR
912
DELISTED
Neustar Inc
NSR
| $7.35M | 0.01% |
298,498
-8,800
| -3% | -$222K |
|
|
DO
913
DELISTED
Diamond Offshore Drilling
DO
| $7.35M | 0.01% |
274,200
+4,371
| +2% | +$136K |
|
914
FerroAtlántica
GSM
$858M
| $7.34M | 0.01% |
387,797
-7,400
| -2% | -$125K |
|
915
IDEX
IEX
$17.3B
| $7.33M | 0.01% |
96,701
+10,600
| +12% | +$798K |
|
|
SFLY
916
DELISTED
Shutterfly, Inc.
SFLY
| $7.32M | 0.01% |
161,799
-1,800
| -1% | -$81.7K |
|
917
TransAlta
TAC
$3.95B
| $7.27M | 0.01% |
783,466
-31,750
| -4% | -$288K |
|
918
Revvity
RVTY
$12.8B
| $7.26M | 0.01% |
142,048
-19,595
| -12% | -$908K |
|
|
ANN
919
DELISTED
ANN INC
ANN
| $7.25M | 0.01% |
176,642
+3,744
| +2% | +$137K |
|
920
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$797M
| $7.22M | 0.01% |
260,443
+39,972
| +18% | +$1.15M |
|
921
Woodward
WWD
$21.5B
| $7.22M | 0.01% |
141,508
+3,793
| +3% | +$181K |
|
922
Pitney Bowes
PBI
$2.41B
| $7.21M | 0.01% |
309,006
-37,494
| -11% | -$873K |
|
|
TE
923
DELISTED
TECO ENERGY INC
TE
| $7.18M | 0.01% |
370,042
+10,772
| +3% | +$218K |
|
924
CAE Inc. Common Shares
CAE
$8.74B
| $7.17M | 0.01% |
614,477
-219,128
| -26% | -$2.68M |
|
925
Herbalife
HLF
$1.26B
| $7.17M | 0.01% |
335,366
-612,428
| -65% | -$10.5M |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.